RenovoRx Revenue

RenovoRx had revenue of $266.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $928.00K. In the year 2024, RenovoRx had annual revenue of $43.00K.

Revenue (ttm)

$928.00K

Revenue Growth

n/a

P/S Ratio

32.38

Revenue / Employee

$92,800

Employees

Market Cap

29.35M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RNXT News

12 days ago - RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum - GlobeNewsWire
13 days ago - RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting - GlobeNewsWire
4 weeks ago - RenovoRx Establishes RenovoCath® Medical Advisory Board - GlobeNewsWire
4 weeks ago - RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer - GlobeNewsWire
5 weeks ago - RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting - GlobeNewsWire
6 weeks ago - RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting - GlobeNewsWire
7 weeks ago - RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center - GlobeNewsWire
2 months ago - RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026 - GlobeNewsWire

More News